Navigation Links
Five New Anti-Inflammatory Compounds Produced By Indian Scientists

Five new anti-inflammatory compounds (fight against inflammation) that are 10, 000 times more potent than the most commonly used drugs such as nimusulide and aspirin have been developed and patented by Indian researchers.// Researchers from the All India Institute of Medical Sciences (AIIMS), situated in New Delhi, India, have carried out the work.

"These compounds are about 10,000 times better than the commonly used pain drugs such as nimesulide and aspirin in terms of potency. We have already reached an understanding with a company to carry the work forward. Since these compounds are peptides, clinical studies on humans may directly begin, without animals studies ", said T P Singh, All India Institute of Medical Sciences (AIIMS).

Inflammation is a condition characterized by pain and swelling. It is associated with a number of diseases, more specifically, arthritis. The anti-inflammatory drugs, which are commercially available (NSAIDS), are associated with a number of adverse effects. However, this effect would not be seen in the newly discovered compounds as it contains peptides, a major component of tissue.

Another significant problem encountered with the use of non-steroidal anti-inflammatory drugs (NSAIDS) is the lack of target specificity. Moreover, the use of such drugs hinders the functioning of other enzymes that play a vital role in the metabolic process. The incidence of gastrointestinal problems is yet another disadvantage, that restricts use of painkillers.
'"/>




Page: 1

Related medicine news :

1. The Usage Of Anti-Inflammatory Drugs Questioned
2. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
3. Non-Steroidal Anti-Inflammatory Drugs Can Cause Liver Damages
4. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
5. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
6. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
7. Sugars Could Contain Key Cancer Inhibiting Compounds
8. Compounds in Licorice Can Fight Tooth Decay
9. Compounds In Legume May Be Helpful In Treating Cancer
10. Beans Devoid Of Flatulence Causing Compounds Would Soon Hit The Market
11. CLA Compounds Fight Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... ... May 23, 2017 , ... Therachat , a ... survey in an infographic on the current state of anxiety in support of National ... anxiety, was conducted in April 2017 and benchmarked general anxiety levels as well as ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... PITTSBURGH, PA (PRWEB) , ... May 22, 2017 , ... ... way to write with a pen. "My wife’s hand was damaged in a firework ... invent something that helps people with manual problems." , He then designed and created ...
(Date:5/22/2017)... ... 22, 2017 , ... Faithfully following pop culture, people today are forever in ... shaped through fitness programs. It carries on to skin nourished, pampered and nurtured to ... radiant smile. CDA has found that just like a perfectly cut and ...
(Date:5/21/2017)... ... May 19, 2017 , ... Chris Cornell, 52, was found dead on the night of Wednesday, ... most respected lead singers in the rock industry would take his own life, but the ... investigates how mental illness played a role in the death of Chris Cornell . ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology: